Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 14, 2023
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
Gregory Renza Reiterated (ACAD) at Buy and Held Target at $27 on, Mar 14th, 2023
Gregory Renza of RBC Capital, Reiterated "ACADIA Pharmaceuticals Inc." (ACAD) at Buy and Held Target at $27 on, Mar 14th, 2023.
Gregory has made no other calls on ACAD in the last 4 months.
There are 5 other peers that have a rating on ACAD. Out of the 5 peers that are also analyzing ACAD, 4 agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Uy Ear of "Mizuho" Reiterated at Hold and Held Target at $19 on, Monday, March 13th, 2023
- Jay Olson of "Oppenheimer" Maintained at Hold with Increased Target to $20 on, Wednesday, March 1st, 2023
- Jason West of "JMP Securities" Maintained at Hold with Decreased Target to $22 on, Tuesday, February 28th, 2023
- Tessa Romero of "JP Morgan" Maintained at Hold with Decreased Target to $17 on, Monday, November 14th, 2022
This is the rating of the analyst that currently disagrees with Gregory
- Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $22 on, Tuesday, January 3rd, 2023
